Human sTNF-R (80kDa) Platinum ELISA

Description: The human sTNF-R (80 kDa) ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human sTNF-R (80 kDa). The human sTNF-R (80 kDa) ELISA is for research use only. Not for diagnostic or therapeutic procedures.

Tumor Necrosis Factor (TNF) was originally discovered in sera of animals and was found to cause hemorrhagic necrosis of some transplantable mouse and human tumors and to exhibit primarily cytotoxic activities against tumor but not normal cells in vitro. The TNF family consists of two proteins designated TNF-alpha, also called cachectin, and TNF-beta, also called lymphotoxin, which are pleiotropic cytokines that can mediate a wide variety of biological effects.

Both TNF-alpha and TNF-beta have been shown to interact with a cell through specific high affinity receptors with a few hundred up to more than 20,000 copies per cell. TNF-receptors have been demonstrated on a wide variety of human somatic cells including fibroblasts, endothelial cells, adipocytes, liver membranes, granulocytes and several tumor cell lines.

The predicted amino acid sequences of the extracellular regions of the two TNF-R reveal significant similarities. They share 28 % identity on their extracellular domain, but their intracellular parts are totally different from each other.

The present assay provides a simple, rapid and highly sensitive method for the determination of soluble TNF-R (80 kDa) levels in body fluids or cell culture supernatants. This assay will help to clarify the possible diagnostic and prognostic value of circulating sTNF-R (80 kDa) in various neoplastic and inflammatory diseases.

Citations: Mavridis,G.; Souliou,E.; Diza,E.; Symeonidis,G.; Pastore,F.; Vassiliou,A.M.; Karamitsos,D.. Inflammatory cytokines in insulin-treated patients with type 2 diabetes. Nutrition, Metabolism and Cardiovascular Diseases 2008;18:471-476. (Link)

Annique,S.; Dorien,T.; Richel,L.; Gunter,K.; Joris,D.; Crijns Harry,J.; Gert,G.; Frank,S.; Michael,M.; Adriaan,H.. Inflammatory markers in depressed post-myocardial infarction patients. Journal of Psychiatric Research 2005;39:137-144. (Link)

Airaghi,Lorena; Lettino,Maddalena; Manfredi,Maria Grazia; Lipton,James Matthew; Catania,Anna. Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. American Heart Journal 1995;130:(Link)

Stojanov,S.; Dejaco,C.; Lohse,P.; Huss,K.; Duftner,C.; Belohradsky,B.H.; Herold,M.; Schirmer,M.. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Annals of the Rheumatic Diseases 2008;67:1292-1298. (Link)

Kato,Akihiko; Odamaki,Mari; Takita,Takako; Furuhashi,Mitsuyoshi; Maruyama,Yukitaka; Hishida,Akira. High blood soluble receptor p80 for tumour necrosis factor-{alpha} is associated with erythropoietin resistance in haemodialysis patients. Nephrology Dialysis Transplantation 2001;16:1838-1844. (Link)

Zoppini,Giacomo; Faccini,Giovanni; Muggeo,Michele; Zenari,Luciano; Falezza,Giancarlo; Targher,Giovanni. Elevated Plasma Levels of Soluble Receptors of TNF-{alpha} and Their Association with Smoking and Microvascular Complications in Young Adults with Type 1 Diabetes. Journal of Clinical Endocrinology & Metabolism 2001;86:3805-3808. (Link)

Wang,Lin; Chen,Rong Fu; Liu,Jien Wei; Yu,Hong Ren; Kuo,Ho Chang; Yang,Kuender D.. Implications of Dynamic Changes among Tumor Necrosis Factor-{alpha} (TNF-{alpha}), Membrane TNF Receptor, and Soluble TNF Receptor Levels in Regard to the Severity of Dengue Infection. American Journal of Tropical Medicine and Hygiene 2007;77:297-302. (Link)

Kato,Akihiko; Odamaki,Mari; Hishida,Akira. Blood 8-hydroxy-2'-deoxyguanosine is associated with erythropoietin resistance in haemodialysis patients. Nephrology Dialysis Transplantation 2003;18:931-936. (Link)

Dai; Guzman; Bauer; Costabel. Elevated levels of soluble TNF receptors in bronchoalveolar lavage fluid in extrinsic allergic alveolitis. Clinical & Experimental Allergy 1999;29:1209-1213. (Link)

References: Barrera,P.; Boerbooms,A.M.; Janssen,E.M.; Sauerwein,R.W.; Gallati,H.; Mulder,J.; de,Boo T.; Demacker,P.N.; van de Putte,L.B.; van der Meer,J.W.. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum. 1993;36:1070-1079. (Link)

Smith,C.A.; Davis,T.; Anderson,D.; Solam,L.; Beckmann,M.P.; Jerzy,R.; Dower,S.K.; Cosman,D.; Goodwin,R.G.. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990;248:1019-1023. (Link)

Loetscher,H.; Pan,Y.C.; Lahm,H.W.; Gentz,R.; Brockhaus,M.; Tabuchi,H.; Lesslauer,W.. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 1990;61:351-359. (Link)

Scheurich,P.; Thoma,B.; Ucer,U.; Pfizenmaier,K.. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J.Immunol. 1987;138:1786-1790. (Link)

Schall,T.J.; Lewis,M.; Koller,K.J.; Lee,A.; Rice,G.C.; Wong,G.H.; Gatanaga,T.; Granger,G.A.; Lentz,R.; Raab,H.; .. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990;61:361-370. (Link)

Aggarwal,B.B.; Eessalu,T.E.; Hass,P.E.. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature 1985;318:665-667. (Link)

Brockhaus,M.; Schoenfeld,H.J.; Schlaeger,E.J.; Hunziker,W.; Lesslauer,W.; Loetscher,H.. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc.Natl.Acad.Sci.U.S.A 1990;87:3127-3131. (Link)

Adolf,G.R.; Apfler,I.. A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor, in biological fluids. J.Immunol.Methods 1991;143:127-136. (Link)

Creasey,A.A.; Yamamoto,R.; Vitt,C.R.. A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity. Proc.Natl.Acad.Sci.U.S.A 1987;84:3293-3297. (Link)

Andus,T.; Gross,V.; Holstege,A.; Ott,M.; Weber,M.; David,M.; Gallati,H.; Gerok,W.; Scholmerich,J.. High concentrations of soluble tumor necrosis factor receptors in ascites. Hepatology 1992;16:749-755. (Link)

Tsujimoto,M.; Yip,Y.K.; Vilcek,J.. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. Proc.Natl.Acad.Sci.U.S.A 1985;82:7626-7630. (Link)

Kull,F.C.,Jr.; Jacobs,S.; Cuatrecasas,P.. Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. Proc.Natl.Acad.Sci.U.S.A 1985;82:5756-5760. (Link)

Rubin,B.Y.; Anderson,S.L.; Sullivan,S.A.; Williamson,B.D.; Carswell,E.A.; Old,L.J.. High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors. J.Exp.Med. 1985;162:1099-1104. (Link)

Paul,N.L.; Ruddle,N.H.. Lymphotoxin. Annu.Rev.Immunol. 1988;6:407-438. (Link)

Aderka,D.; Wysenbeek,A.; Engelmann,H.; Cope,A.P.; Brennan,F.; Molad,Y.; Hornik,V.; Levo,Y.; Maini,R.N.; Feldmann,M.; .. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum. 1993;36:1111-1120. (Link)

Beutler,B.; Mahoney,J.; Le,Trang N.; Pekala,P.; Cerami,A.. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J.Exp.Med. 1985;161:984-995. (Link)

Godfried,M.H.; van der,Poll T.; Jansen,J.; Romijin,J.A.; Schattenkerk,J.K.; Endert,E.; van Deventer,S.J.; Sauerwein,H.P.. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS 1993;7:33-36. (Link)

Baglioni,C.; McCandless,S.; Tavernier,J.; Fiers,W.. Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. J.Biol.Chem. 1985;260:13395-13397. (Link)

Scheurich,P.; Ucer,U.; Kronke,M.; Pfizenmaier,K.. Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell lines. Int.J.Cancer 1986;38:127-133. (Link)

Naylor,M.S.; Stamp,G.W.; Foulkes,W.D.; Eccles,D.; Balkwill,F.R.. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J.Clin.Invest 1993;91:2194-2206. (Link)

Heilig,B.; Fiehn,C.; Brockhaus,M.; Gallati,H.; Pezzutto,A.; Hunstein,W.. Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. J.Clin.Immunol. 1993;13:321-328. (Link)

Lantz,M.; Malik,S.; Slevin,M.L.; Olsson,I.. Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine 1990;2:402-406. (Link)

Peetre,C.; Thysell,H.; Grubb,A.; Olsson,I.. A tumor necrosis factor binding protein is present in human biological fluids. Eur.J.Haematol. 1988;41:414-419. (Link)

Munker,R.; DiPersio,J.; Koeffler,H.P.. Tumor necrosis factor: receptors on hematopoietic cells. Blood 1987;70:1730-1734. (Link)

Himmler,A.; Maurer-Fogy,I.; Kronke,M.; Scheurich,P.; Pfizenmaier,K.; Lantz,M.; Olsson,I.; Hauptmann,R.; Stratowa,C.; Adolf,G.R.. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein. DNA Cell Biol. 1990;9:705-715. (Link)